Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Study of Pembrolizumab and Olaparib in Bile Duct Cancer

Phase 2

Active, not recruiting

Conditions: Cholangiocarcinoma

Interventions: Drug: Pembrolizumab
Drug: Olaparib

First Posted Date: 2020-03-12

Last Posted Date: 2024-12-17

Lead Sponsor: Georgetown University

Target Recruit Count: 14

Registration Number: NCT04306367

Locations: 🇺🇸
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, United States

Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma

Phase 1

Active, not recruiting

Conditions: Locally Advanced Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Ductal Adenocarcinoma

Interventions: Biological: Eryaspase
Drug: FOLFIRINOX

First Posted Date: 2020-03-03

Last Posted Date: 2023-12-21

Lead Sponsor: Georgetown University

Target Recruit Count: 19

Registration Number: NCT04292743

Locations: 🇺🇸
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

Improving Genetic Counseling for BRCA+ Mothers

Not Applicable

Recruiting

Conditions: Breast Cancer

Interventions: Behavioral: Education
Behavioral: Education and counseling

First Posted Date: 2020-02-06

Last Posted Date: 2024-09-27

Lead Sponsor: Georgetown University

Target Recruit Count: 200

Registration Number: NCT04258280

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States

Optimizing Hookah Tobacco Public Education Messages to Reduce Young Adult Use

Not Applicable

Completed

Conditions: Hookah Tobacco Smoking

Interventions: Behavioral: Hookah tobacco messages

First Posted Date: 2020-02-05

Last Posted Date: 2023-02-13

Lead Sponsor: Georgetown University

Target Recruit Count: 830

Registration Number: NCT04252014

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

Peer Support For Young Adult Women With High Breast Cancer Risk

Not Applicable

Recruiting

Conditions: Breast Cancer Risk

Interventions: Behavioral: PeACE
Behavioral: Community peer coaching

First Posted Date: 2020-01-30

Last Posted Date: 2024-04-23

Lead Sponsor: Georgetown University

Target Recruit Count: 560

Registration Number: NCT04248257

Locations: 🇺🇸
University of Texas Southwestern Medical Center, Dallas, Texas, United States
🇺🇸
Dana Farber Cancer Center, Boston, Massachusetts, United States
🇺🇸
University of Washington, Seattle, Washington, United States

and more 3 locations

Safety and Tolerability of Oral Proglumide for NASH

Phase 1

Completed

Conditions: Nonalcoholic Steatohepatitis

Interventions: Drug: Proglumide

First Posted Date: 2019-11-05

Last Posted Date: 2022-10-13

Lead Sponsor: Georgetown University

Target Recruit Count: 18

Registration Number: NCT04152473

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States
🇺🇸
Washington DC Veterans Affairs Medical Center, Washington, District of Columbia, United States

Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects

Not Applicable

Completed

Conditions: Diabetes Mellitus

Interventions: Dietary Supplement: Ginger Water
Dietary Supplement: Ginger Kombucha

First Posted Date: 2019-09-27

Last Posted Date: 2020-07-30

Lead Sponsor: Georgetown University

Target Recruit Count: 12

Registration Number: NCT04107207

Locations: 🇺🇸
Georgetown University MedStar Hospital, Washington, District of Columbia, United States

Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma

Phase 2

Active, not recruiting

Conditions: Melanoma

Interventions: Drug: Nivolumab
Drug: Ipilimumab
Drug: Cabozantinib

First Posted Date: 2019-09-17

Last Posted Date: 2024-11-27

Lead Sponsor: Georgetown University

Target Recruit Count: 14

Registration Number: NCT04091750

Locations: 🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
Medstar Franklin Square Medical Center, Harry and Jeanette Weinberg Cancer Institute, Baltimore, Maryland, United States
🇺🇸
Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States

"Immunomodulation in GWI (Phlebotomy)"

Conditions: Gulf War Illness

Interventions: Other: Draw blood (phlebotomy, 83 ml)

First Posted Date: 2019-08-15

Last Posted Date: 2019-08-15

Lead Sponsor: Georgetown University

Target Recruit Count: 80

Registration Number: NCT04058275

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

A Mobile Text Messaging Intervention for Indoor Tanning Addiction

Not Applicable

Completed

Conditions: Indoor Tanning

Interventions: Behavioral: Mobile text messaging intervention

First Posted Date: 2019-08-13

Last Posted Date: 2022-08-04

Lead Sponsor: Georgetown University

Target Recruit Count: 265

Registration Number: NCT04055272

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy